We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Blood-Clot Drug Buyers Seek Class Cert. In Antitrust Suit

Law360 (November 19, 2018, 8:11 PM EST) -- Indirect purchasers of blood clot drug Lovenox and its generic version asked a Tennessee federal court for class certification in their suit alleging Momenta Pharmaceuticals Inc. and Sandoz Inc. conspired to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.